California Cancer Reporting System Standards, Volume III
CS
California Hospital Transmit
Eureka Admission Level
Eureka Tumor Level
Primary Site [NAACCR #400]
Histologic Type ICD-O-3 [NAACCR #522]
Behavior Code ICD-O-3 [NAACCR# 523]
CS Lymph Nodes [NAACCR #2830]
CS Site Specific Factor2 [NAACCR #2890]
CS Site-Specific Factor25 [NAACCR #2879]
CS Version Input Original [NAACCR #2935]
None
IF 1115: PeritoneumFemaleGen schema: If CS Lymph Nodes = [value], CS Site-Specific Factor2 must not = [value]
The purpose of this edit is to verify that the CS Site-Specific Factor 2 (FIGO Stage) and CS Lymph Nodes are coded consistently for PeritoneumFemaleGen cases that are originally coded using CSv02.05 or higher.
This edit is skipped if any of the following conditions are true:
1. CS Version Input Original is less than 020500
2. CS schema is not PeritoneumFemaleGen
3. CS Site-Specific Factor 2 is blank or 988
4. CS Lymph Nodes is blank
5. Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)
If schema is PeritoneumFemaleGen:
1. If CS Lymph Nodes not = 000 (no regional lymph nodes involvement) or 999 (unknown), then CS Site-Specific Factor 2 must not = 100, 110, 120, 130, 200, 210, 220, 230, 310, or 320 (codes indicating FIGO Stage I, II, IIIA, IIIB).
In the SEER*Edits software, the title of this edit is: IF498. |
|
04/2014 |
New edit added to NAACCR v14 metafile. |